Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:AET
CUSIP00817Y10
Phone860-273-0123
Debt
Debt-to-Equity Ratio0.52%
Current Ratio0.65%
Quick Ratio0.65%
Price-To-Earnings
Trailing P/E Ratio18.00
Forward P/E Ratio16.07
P/E Growth1.43
Sales & Book Value
Annual Sales$60.54 billion
Price / Sales0.96
Cash Flow$12.4543 per share
Price / Cash14.22
Book Value$48.46 per share
Price / Book3.65
Profitability
EPS (Most Recent Fiscal Year)$9.86
Net Income$1.90 billion
Net Margins3.15%
Return on Equity21.50%
Return on Assets5.87%
Miscellaneous
Employees47,950
Outstanding Shares326,940,000
Aetna (NYSE:AET) Frequently Asked Questions
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Friday, February 23rd. Shareholders of record on Thursday, April 12th will be paid a dividend of $0.50 per share on Friday, April 27th. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend is Wednesday, April 11th. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna announced that its Board of Directors has initiated a stock buyback program on Friday, April 7th 2017, which allows the company to buyback $4,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 98% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its stock is undervalued.
How were Aetna's earnings last quarter?
Aetna (NYSE:AET) issued its quarterly earnings data on Tuesday, January, 30th. The company reported $1.25 EPS for the quarter, topping the Zacks' consensus estimate of $1.18 by $0.07. The firm earned $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a net margin of 3.15% and a return on equity of 21.50%. The company's quarterly revenue was down 6.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.08 earnings per share. View Aetna's Earnings History.
When is Aetna's next earnings date?
What price target have analysts set for AET?
18 analysts have issued twelve-month target prices for Aetna's shares. Their forecasts range from $158.00 to $212.00. On average, they expect Aetna's share price to reach $189.8235 in the next year. View Analyst Ratings for Aetna.
What are Wall Street analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. According to Zacks Investment Research, "Aetna’s third-quarter earnings surpassed the Zacks Consensus Estimate and grew year over year, driven by strong underwriting margin performance, disciplined pricing, a focus on high quality care management, and a decline in medical cost. Aetna’s shares have outperformed the industry year to date. We expect the company to witness long-term growth from its Government business and International expansion. Its cost-reduction initiatives will aid margins. The sale of its Group Life and Disability business will help it to focus on core growth areas. Following strong third-quarter results, Aetna raised its earnings guidance, cementing investors' confidence in it. Aetna has, however, been incurring losses in its public exchange business and has been exiting exchanges. Furthermore, its membership growth remains under pressure. Increasing medical benefit ratios are also likely to hurt margins." (11/2/2017)
- 2. Cantor Fitzgerald analysts commented, "There is life after Humana. CEO Mark Bertolini opened the meeting discussing life after Humana. With a continued focus to grow its government business, Mr. Bertolini indicated that Humana represented a means to an end." Instead, AET will now chose to build its government business organically. We believe the company will also pursue acquisitions to build out its capabilities in specific geographies. CFO Shawn Guertin identified Medicare as a great growth opportunity, but characterized Medicaid as a good opportunity. Growth in Medicaid slowed recently due to two contract losses and potential for structural changes to Medicaid exist." (5/12/2017)
- 3. Royal Bank of Canada analysts commented, "After the close on Monday, April 24, Humana pre-released 1Q17 EPS ahead of its investor meeting, which will be held on Tuesday, April 25. 1Q17 Adjusted EPS for the quarter was $2.75 vs. our estimate of $2.50 and FactSet consensus of $2.49." (4/24/2017)
Who are some of Aetna's key competitors?
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
- Ms. Karen Sue Lynch, Pres (Age 55)
- Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
- Mr. Thomas J. Sabatino Jr., Exec. VP & Gen. Counsel (Age 59)
- Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)
Has Aetna been receiving favorable news coverage?
Press coverage about AET stock has trended somewhat positive on Tuesday, Accern reports. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aetna earned a coverage optimism score of 0.09 on Accern's scale. They also gave headlines about the company an impact score of 45.38 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
How do I buy shares of Aetna?
Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of AET stock can currently be purchased for approximately $177.10.
How big of a company is Aetna?
Aetna has a market capitalization of $57.84 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.
How can I contact Aetna?
Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]
MarketBeat Community Rating for Aetna (AET)
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.
Aetna (NYSE:AET) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
18 Wall Street analysts have issued ratings and price targets for Aetna in the last 12 months. Their average twelve-month price target is $189.8235, suggesting that the stock has a possible upside of 7.18%. The high price target for AET is $212.00 and the low price target for AET is $158.00. There are currently 7 hold ratings and 11 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.61 | 2.65 | 2.64 | 2.65 |
| Ratings Breakdown: | 0 Sell Rating(s)
7 Hold Rating(s)
11 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
8 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
7 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $189.8235 | $189.8235 | $177.5556 | $163.4706 |
| Price Target Upside: | 7.18% upside | 1.27% upside | 5.45% downside | 8.47% downside |
Aetna (NYSE:AET) Consensus Price Target History
Aetna (NYSE:AET) Analyst Ratings History
Show:
(Data available from 4/24/2016 forward)
Aetna (NYSE:AET) Dividend Information
Aetna pays an annual dividend of $2.00 per share, with a dividend yield of 1.13%. AET's next quarterly dividend payment will be made on Friday, April 27. Aetna pays out 20.28% of its earnings out as a dividend.
| Next Dividend: | 4/27/2018 |
| Annual Dividend: | $2.00 |
| Dividend Yield: | 1.13% |
| Dividend Growth: | 24.80% (3 Year Average) |
| Payout Ratio: | 20.28% (Trailing 12 Months of Earnings)
18.15% (Based on This Year's Estimates)
16.34% (Based on Next Year's Estimates)
|
| Frequency: | Quarterly Dividend |
Aetna (NYSE:AET) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/23/2018 | quarterly | $0.50 | 1.13726828158763% | 4/11/2018 | 4/12/2018 | 4/27/2018 |
| 12/4/2017 | quarterly | $0.50 | 1.12% | 1/10/2018 | 1/11/2018 | 1/26/2018 |
| 9/29/2017 | quarterly | $0.50 | 1.25% | 10/11/2017 | 10/12/2017 | 10/27/2017 |
| 5/19/2017 | quarterly | $0.50 | 1.42% | 7/11/2017 | 7/13/2017 | 7/28/2017 |
| 2/17/2017 | quarterly | $0.50 | 1.58% | 4/11/2017 | 4/13/2017 | 4/28/2017 |
| 12/2/2016 | quarterly | $0.25 | 0.77% | 1/10/2017 | 1/12/2017 | 1/27/2017 |
| 9/30/2016 | quarterly | $0.25 | 0.87% | 10/11/2016 | 10/13/2016 | 10/28/2016 |
| 5/20/2016 | quarterly | $0.25 | 0.91% | 7/12/2016 | 7/14/2016 | 7/29/2016 |
| 2/19/2016 | quarterly | $0.25 | 0.94% | 4/12/2016 | 4/14/2016 | 4/29/2016 |
| 12/4/2015 | quarterly | $0.25 | 0.97% | 1/12/2016 | 1/14/2016 | 1/29/2016 |
| 9/25/2015 | quarterly | $0.25 | 0.95% | 10/13/2015 | 10/15/2015 | 10/30/2015 |
| 5/15/2015 | quarterly | $0.25 | 0.88% | 7/14/2015 | 7/16/2015 | 7/31/2015 |
| 2/27/2015 | quarterly | $0.25 | 1% | 4/7/2015 | 4/9/2015 | 4/24/2015 |
| 11/21/2014 | quarterly | $0.25 | 1.15% | 1/13/2015 | 1/15/2015 | 1/30/2015 |
| 9/19/2014 | quarterly | $0.2250 | 1.08% | 10/14/2014 | 10/16/2014 | 10/31/2014 |
| 5/30/2014 | quarterly | $0.2250 | 1.16% | 7/8/2014 | 7/10/2014 | 7/25/2014 |
| 2/28/2014 | quarterly | $0.2250 | 1.25% | 4/8/2014 | 4/10/2014 | 4/25/2014 |
| 12/6/2013 | quarterly | $0.2250 | 1.35% | 1/14/2014 | 1/16/2014 | 1/31/2014 |
| 9/27/2013 | quarterly | $0.20 | 1.25% | 10/8/2013 | 10/10/2013 | 10/25/2013 |
| 5/17/2013 | quarterly | $0.20 | 1.35% | 7/9/2013 | 6/11/2013 | 7/26/2013 |
| 2/19/2013 | quarterly | $0.20 | 1.66% | 4/9/2013 | 4/11/2013 | 4/26/2013 |
(Data available from 1/1/2013 forward)
Aetna (NYSE AET) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.21%
Institutional Ownership Percentage: 87.22%
Aetna (NYSE AET) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/18/2017 | Karen S Lynch | President | Sell | 15,271 | $161.91 | $2,472,527.61 | 64,261 |  |
| 9/15/2017 | Margaret M Mccarthy | EVP | Sell | 10,288 | $162.85 | $1,675,400.80 | 33,563 | |
| 6/7/2017 | Margaret M Mccarthy | EVP | Sell | 27,028 | $149.23 | $4,033,388.44 | 33,563 | |
| 5/17/2017 | Mark T Bertolini | Chairman | Sell | 103,547 | $140.79 | $14,578,382.13 | 659,888 | |
| 3/23/2017 | Shawn M Guertin | Insider | Sell | 29,602 | $129.35 | $3,829,018.70 | 44,880 | |
| 3/8/2017 | Francis S Soistman Jr | VP | Sell | 6,607 | $131.98 | $871,991.86 | 23,454 | |
| 9/7/2016 | Jeffrey E. Garten | Director | Sell | 7,100 | $116.51 | $827,221.00 | | |
| 8/23/2016 | Shawn M Guertin | Insider | Sell | 45,328 | $120.21 | $5,448,878.88 | 44,883 | |
| 5/10/2016 | Margaret M Mccarthy | EVP | Sell | 39,169 | $114.45 | $4,482,892.05 | 56,240 | |
| 5/3/2016 | Mark T Bertolini | CEO | Sell | 33,510 | $114.00 | $3,820,140.00 | 496,588 | |
| 3/15/2016 | Gary W Loveman | EVP | Buy | 8,970 | $111.45 | $999,706.50 | 9,605 | |
| 2/22/2016 | Molly Joel Coye | Director | Sell | 1,175 | $106.28 | $124,879.00 | 8,104 | |
| 12/23/2015 | Margaret M Mccarthy | EVP | Sell | 18,373 | $109.97 | $2,020,478.81 | 63,515 | |
| 12/22/2015 | Mark T. Bertolini | CEO | Sell | 26,996 | $110.00 | $2,969,560.00 | 729,194 | |
| 8/14/2015 | Joseph M Zubretsky | EVP | Sell | 179,087 | $118.66 | $21,250,463.42 | | |
| 8/13/2015 | Franklin Barbara Hackman | Director | Sell | 2,064 | $118.47 | $244,522.08 | | |
| 3/31/2015 | Joseph M Zubretsky | EVP | Sell | 200,000 | $107.96 | $21,592,000.00 | | |
| 3/27/2015 | Joseph M Zubretsky | EVP | Sell | 86,958 | $107.24 | $9,325,375.92 | | |
| 3/26/2015 | Joseph M Zubretsky | Insider | Sell | 162,066 | $106.98 | $17,337,820.68 | | |
| 3/26/2015 | Margaret M Mccarthy | EVP | Sell | 27,670 | $106.04 | $2,934,126.80 | | |
| 3/25/2015 | Franklin Barbara Hackman | Director | Sell | 3,000 | $108.75 | $326,250.00 | | |
| 3/17/2015 | William James Casazza | VP | Sell | 14,000 | $105.07 | $1,470,980.00 | | |
| 3/2/2015 | Molly Joel Coye | Director | Sell | 2,500 | $100.27 | $250,675.00 | | |
| 2/10/2015 | Rajan Parmeswar | VP | Sell | 5,300 | $95.60 | $506,680.00 | | |
| 6/16/2014 | Molly Joel Coye | Director | Sell | 1,650 | $80.60 | $132,990.00 | | |
| 6/12/2014 | William James Casazza | VP | Sell | 15,906 | $80.58 | $1,281,705.48 | | |
| 5/27/2014 | Franklin Barbara Hackman | Director | Sell | 2,665 | $77.26 | $205,897.90 | | |
| 2/19/2014 | Rajan Parmeswar | VP | Sell | 3,600 | $69.46 | $250,056.00 | 3,829 | |
| 12/30/2013 | Mark Bertolini | CEO | Sell | 130,272 | $68.08 | $8,868,917.76 | 526,938 | |
| 12/27/2013 | William James Casazza | VP | Sell | 10,299 | $68.25 | $702,906.75 | 33,903 | |
| 8/26/2013 | William James Casazza | VP | Sell | 15,745 | $64.66 | $1,018,071.70 | 33,903 | |
| 6/18/2013 | William James Casazza | VP | Sell | 40,598 | $62.00 | $2,517,076.00 | | |
| 5/21/2013 | Molly Joel Coye | Director | Sell | 2,000 | $60.38 | $120,760.00 | | |
| 5/20/2013 | Joseph P Newhouse | Director | Sell | 14,000 | $59.15 | $828,100.00 | | |
| 5/15/2013 | Rajan Parmeswar | VP | Sell | 1,435 | $60.13 | $86,286.55 | | |
| 2/6/2013 | Karen Rohan | VP | Buy | 4,035 | $49.53 | $199,853.55 | | |
(Data available from 1/1/2013 forward)
Aetna (NYSE AET) News Headlines
| Source: |
|
Aetna (NYSE:AET) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Aetna (NYSE:AET) Income Statement, Balance Sheet and Cash Flow Statement
Aetna (NYSE AET) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
